Source:http://linkedlifedata.com/resource/pubmed/id/17853492
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-17
|
pubmed:abstractText |
Towards the goal of identifying tumor-rejection antigens on eradicated tumors in bone and soft tissue sarcomas, we evaluated the immune response against antigens presented by lost HLA class I molecules. Tumor specimens and peripheral blood samples were obtained from a 70-year-old woman with pleomorphic malignant fibrous histiocytoma. Over 1-year culture, a tumor cell line (MFH2004) was established. A B-cell line infected with Epstein-Barr virus (B2004-EBV) was developed from the blood samples. HLA genotypes of B2004-EBVcells were A*0206/2402, B*4006/4601, and C*0102/0801, whereas MFH2004 cells were defective for A*0206, B*4006, and C*0102. Loss of HLA-A2 expression was also proved immunohistochemically in the primary tumor tissues. Lost HLA-A2 in MFH2004 cells was retrieved by transfection of HLA-A*0206 cDNA to develop MFH2004-A2. Attempts to induce CTLs by mixed culture with autologous T cells and MFH2004 cells resulted in failure. In contrast, those with MFH2004-A2 induced CTL clones CTL2004-c6 and CTL2004-c17. These CTL clones specifically killed MFH2004-A2 but not MFH2004 or B2004-EBV in an HLA-A2-restricted manner. These findings suggest that CTL2004-c6 and CTL2004-c17 recognize autologous tumor-rejection antigens presented by HLA-A*0206, which may have been expressed by tumor cells that had been eradicated by the host's immunosurveillance system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A2 Antigen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1554-527X
|
pubmed:author |
pubmed-author:IdaKazunoriK,
pubmed-author:KawaguchiSatoshiS,
pubmed-author:KayaMitunoriM,
pubmed-author:KimuraShigeharuS,
pubmed-author:KozakaiYurikoY,
pubmed-author:MatsumuraTadakiT,
pubmed-author:MuraseMasakiM,
pubmed-author:SatoNoriyukiN,
pubmed-author:TorigoeToshihikoT,
pubmed-author:TsukaharaTomohideT,
pubmed-author:WadaTakuroT,
pubmed-author:YamashitaToshihikoT
|
pubmed:copyrightInfo |
(c) 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
271-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17853492-Aged,
pubmed-meshheading:17853492-Antigen Presentation,
pubmed-meshheading:17853492-Antigens, Neoplasm,
pubmed-meshheading:17853492-Autoantigens,
pubmed-meshheading:17853492-Cell Line, Tumor,
pubmed-meshheading:17853492-DNA, Complementary,
pubmed-meshheading:17853492-Female,
pubmed-meshheading:17853492-Genotype,
pubmed-meshheading:17853492-HLA Antigens,
pubmed-meshheading:17853492-HLA-A Antigens,
pubmed-meshheading:17853492-HLA-A2 Antigen,
pubmed-meshheading:17853492-Herpesvirus 4, Human,
pubmed-meshheading:17853492-Histiocytoma, Malignant Fibrous,
pubmed-meshheading:17853492-Humans,
pubmed-meshheading:17853492-T-Lymphocytes,
pubmed-meshheading:17853492-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:17853492-Transfection
|
pubmed:year |
2008
|
pubmed:articleTitle |
Clonal T-cell response against autologous pleomorphic malignant fibrous histiocytoma antigen presented by retrieved HLA-A*0206.
|
pubmed:affiliation |
Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|